Yalonda Howze
Net Worth
Last updated:
What is Yalonda Howze net worth?
The estimated net worth of Ms. Yalonda Howze is at least $647,899 as of 30 Mar 2023. She has earned $2,139 from insider trading and has received compensation worth at least $645,760 in Codiak BioSciences, Inc..
What is the salary of Yalonda Howze?
Ms. Yalonda Howze salary is $322,880 per year as Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec. in Codiak BioSciences, Inc..
How old is Yalonda Howze?
Ms. Yalonda Howze is 53 years old, born in 1972.
What stocks does Yalonda Howze currently own?
As insider, Ms. Yalonda Howze owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Codiak BioSciences, Inc. (CDAK) | Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec. | 7,458 | $0 | $0 |
What does Codiak BioSciences, Inc. do?
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Yalonda Howze insider trading
Codiak BioSciences, Inc.
Ms. Yalonda Howze has made 3 insider trades in 2023, according to the Form 4 filled with the SEC. Most recently she sold 1,628 units of CDAK stock worth $319 on 30 Mar 2023.
The largest trade she's ever made was exercising 4,856 units of CDAK stock on 16 Feb 2023. As of 30 Mar 2023 she still owns at least 7,458 units of CDAK stock.
Codiak BioSciences key executives
Codiak BioSciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Douglas Edward Williams Ph.D. (67) Pres, Chief Executive Officer & Director
- Ms. Yalonda Howze (53) Executive Vice President, Chief Legal Officer, Chief Compliance Officer & Corporation Sec.